Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-20-051890

Director bought 3,056 shares at $4.66 ($14,241)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
CONWAY ROBERT E Director 2020-09-22 Purchase +3,056 $4.66 $14,241 15,000 D
Open-market purchases · 3,056 sh · avg $4.66 · $14,241
Loading xslF345X03/doc4.xml…